IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q2 2016 Holdings

Filed 2016-08-15 | 32 holdings | $128.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$48.5M2,627,71937.9%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$45.3M3,412,85735.3%
Ardelyx Inc(ARDX)COM039697107$20.2M2,312,24315.8%
Biocryst Pharmaceuticals(BCRX)COM09058V103$8.5M2,989,7956.6%
Beigene LTD(ONC)SPONSORED ADR07725L102$5.1M170,0004.0%
Wave Life Sciences LTD(WVE)SHSY95308105$146.7K7,088,6510.1%
Achillion Pharmaceuticals Inc(ACHNEUR)COM00448Q201$93.9K12,033,2200.1%
Axovant Sciences LTDCOMG0750W104$64.2K5,000,0000.1%
Avexis IncCOM05366U100$50.9K1,339,3820.0%
Nektar Therapeutics(NKTREUR)COM640268108$45.9K3,224,8540.0%
TG Therapeutics Inc(TGTX)COM88322Q108$27.5K4,531,7140.0%
Zogenix IncCOM NEW98978L204$19.7K2,451,2370.0%
Vitae Pharmaceuticals IncCOM92847N103$17.0K1,575,0000.0%
Aimmune Therapeutics Inc(AIMT)COM00900T107$14.0K1,292,9400.0%
Alcobra LTDSHSM2239P109$13.6K3,032,9110.0%
Proteon Therapeutics IncCOM74371L109$13.1K1,626,9310.0%
Aquinox Pharmaceuticals IncCOM03842B101$11.2K1,691,9770.0%
Strongbridge Biopharma PLCSHS USDG85347105$10.6K2,675,3380.0%
Natera Inc(NTRA)COM632307104$9.5K783,5200.0%
Dimension Therapeutics IncCOM25433V105$9.3K1,548,0330.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$7.3K2,428,5710.0%
Sangamo Biosciences Inc(SGMO)COM800677106$6.8K1,165,9380.0%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$6.5K853,1510.0%
Tenax Therapeutics IncCOM88032L100$6.1K2,389,7000.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$5.8K291,7000.0%
Cidara Therapeutics IncCOM171757107$4.2K410,8090.0%
Akari Therapeutics PLCSPONSORED ADR00972G108$3.2K234,2400.0%
Aeglea Biotherapeutics Inc(AGLEUSD)COM00773J103$2.5K521,5500.0%
Merus N VCOMN5749R100$1.9K237,5990.0%
Zynerba Pharmaceuticals IncCOM98986X109$1.7K253,4680.0%
Arca Biopharma IncCOM PAR$.00100211Y407$1.6K562,6930.0%
Pronai Therapeutics IncCOM74346L101$5929,7190.0%